Research Group Lab Hall

Pharmacology and Toxicology

Pharmacology and Toxicology Research at the Medical College of Wisconsin

Cancer Research

Magdalena Chrzanowska, PhD, FAHA

Professor, Pharmacology and Toxicology; Program Co-Leader, Transfusion Medicine, Vascular Biology and Cell Therapy and Senior Investigator; Versiti Blood Research Institute

Guan Chen, MD, PhD

Professor

Todd W. Miller, PhD

WBCS Professor of Breast Cancer Research and Professor of Pharmacology and Toxicology

Xiao-Mei Qi, MD

Associate Professor

Carol L. Williams, PhD

Joan K. Van Deuren Professor in Breast Cancer Research; Leader, Cancer Biology Research Program, Cancer Center; Professor, Pharmacology & Toxicology

Cardiovascular Research

John A. Auchampach, PhD

Professor

William B. Campbell, PhD

Professor

Magdalena Chrzanowska, PhD, FAHA

Professor, Pharmacology and Toxicology; Program Co-Leader, Transfusion Medicine, Vascular Biology and Cell Therapy and Senior Investigator; Versiti Blood Research Institute

Sandra L. Pfister, PhD

Professor

Neuroscience Research

Alan S. Bloom, PhD

Professor Emeritus

Cecilia J. Hillard, PhD

Professor, Pharmacology and Toxicology; G. Frederick Kasten, Jr. Endowed Chair in Parkinson’s Disease Research

Sang H. Lee, PhD

Professor

Qing-Song Liu, PhD

Professor

Christopher M. Olsen, PhD

Professor, Director of Graduate Studies

Recent News

See All News

Damaris Nieves Torres

Motivated by her Father’s Diagnosis, MCW PhD Student Pursues Alzheimer’s Research

September 18, 2025

Damaris Nieves Torres studies proteins tied to synapse loss in patients that could be a new target for therapies.

John Mantsch, PhD

Understanding Cognitive Inflexibility in Depression

January 17, 2025

Dr. John Mantsch was awarded a grant to study the mechanisms of stress-related cognitive inflexibility.

Chemical structures of levodopa and analogs

Mitigation of Gut Bacterial Metabolism of Levodopa Could Enhance Its Efficacy

June 7, 2024

Communications Biology article discusses a promising therapeutic approach to enhancing the bioavailability of levodopa.

Dr. Jimmy Feix Receives R21 to Study Parkinson's Disease

April 24, 2024

Dr. Feix was awarded a $429,000 R21, titled "Modifying the Microbiome to Enhance L-dopa Therapy in Parkinson’s Disease," from the National Institute of Neurological Disorders and Stroke.

Precision Epidemiology and Overdose

Precision Epidemiology and Overdose

June 1, 2023

MCW scientist Dr. John Mantsch and his partners study overdose patterns to improve prevention strategies.

Main Campus Entrance-MKE

Science Needs More Physicians

July 20, 2022

MCW creates physician-scientist immersion program to address the shortage of US physicians conducting research.

Prostate cancer cell

When Prostate Cancer Returns

June 15, 2022

MCW physician-scientists test new treatment for advanced prostate cancer.

Study Looks at Use of Mitochondria-Targeted Malaria Drug to Prevent Tumor Growth and Dissemination

March 14, 2022

Mitochondria-targeted atovaquone could be an attractive drug to modulate tumor immunity to prevent and treat cancers.

© 2025 Medical College of Wisconsin. All rights reserved. | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The Medical College of Wisconsin (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. MCW maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

MCW's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.